AN

Advanced Nanotherapies

Next Generation Drug-Coated Balloons

Santa Clara, United States · Founded 2018 · $36.3M raised

Headquarters
Santa Clara
Founded
2018
Business Model
B2B
Total Funding
$36.3M
Last Round
$31.0M Series BJun 2026
Rounds
2

About

Advanced NanoTherapies (ANT) is a Santa Clara, California-based clinical-stage medical device company developing SirPlux Duo, a next-generation drug-coated balloon (DCB) therapy for coronary and peripheral artery disease. Powered by ANT's proprietary functionalized nanoparticle drug delivery platform, SirPlux Duo is the only DCB designed to deliver two synergistic drugs, Sirolimus and Paclitaxel, simultaneously and release them in-tissue over the long term to achieve stent-like patency without a permanent stent. The FDA granted SirPlux Duo Breakthrough Device designation for small-vessel coronary artery disease, and ANT closed an oversubscribed $31 million Series B financing in 2026 to advance its clinical program.

Summary

Advanced Nanotherapies is a Healthcare company based in Santa Clara, United States, founded in 2018. It has raised $36.3M in total across 2 rounds, most recently a $31.0M Series B round in Jun 2026. Investors include S3 Ventures.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJun 2026
$31.0M

Sign up to see all 2 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Advanced Nanotherapies on Indexed.vc
<a href="https://indexed.vc/companies/advanced-nanotherapies"><img src="https://indexed.vc/api/badge/company/advanced-nanotherapies" alt="Advanced Nanotherapies on Indexed.vc" width="260" height="76" /></a>